Lonigutamab (hz208F2-4) is a humanized monoclonal antibody targeting the insulin-like growth factor-1 receptor (IGF-1R) for the study of thyroid eye disease.
Purity:
95.30%
Target:
ADC Antibody|||IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted